IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 48 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $274,000 | +158.5% | 265,850 | +202.3% | 0.00% | – |
| Q2 2021 | $106,000 | -74.0% | 87,950 | -71.9% | 0.00% | -100.0% |
| Q1 2021 | $407,000 | +3.8% | 313,251 | +193.0% | 0.00% | 0.0% |
| Q4 2020 | $392,000 | +734.0% | 106,924 | +563.8% | 0.00% | – |
| Q3 2019 | $47,000 | -89.0% | 16,109 | -90.4% | 0.00% | -100.0% |
| Q1 2019 | $427,000 | +23.8% | 167,318 | +34.3% | 0.00% | 0.0% |
| Q4 2018 | $345,000 | +167.4% | 124,606 | +758.4% | 0.00% | – |
| Q3 2018 | $129,000 | – | 14,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |